| Abstract: | Endostatin,a C-terminal fragment of collagen 18a,inhibits the growth of established tumors and metastases in vivo by inhibiting angiogenesis.However,the purification procedures required for large- scale production and the attendant cost of these processes,together with the low effectiveness in clinical tests,suggest that alternative delivery methods might be required for efficient therapeutic use of endostatin. In the present study,we transfected Chinese hamster ovary(CHO)cells with a human endostatin gene expression vector and encapsulated the CHO cells in alginate-poly-L-lysine microcapsules.The release of biologically active endostatin was confirmed using the chicken chorioallantoic membrane assay.The encap- sulated endostatin-expressing CHO cells can inhibit the growth of primary tumors in a subcutaneous B 16 tumor model when injected into the abdominal cavity of mouse.These results widen the clinical application of the microencapsulated cell endostatin delivery system in cancer treatment. |
